The authors respond to “Opioid agonist dosage adequacy from clinical and patient perspectives: further considerations”
AA Artenie, J Bruneau - Cmaj, 2019 - Can Med Assoc
We appreciate the comments by Trujols and colleagues1 on our CMAJ article. 2 We wish to
highlight that the thresholds used to dichotomize the prescribed dosage for opioid agonist …
highlight that the thresholds used to dichotomize the prescribed dosage for opioid agonist …
RE: Opioid agonist dosage adequacy from clinical and patient perspectives: Further considerations
AA Artenie, J Bruneau - 2023 - Can Med Assoc
We appreciate the comments by Trujols et al [1] on our article [2]. We wish to highlight that
the thresholds used to dichotomize the prescribed dose for opioid agonist treatment in our …
the thresholds used to dichotomize the prescribed dose for opioid agonist treatment in our …
Opioid agonist dosage adequacy from clinical and patient perspectives: further considerations
J Trujols, MJ Campins, E Ribalta - Cmaj, 2019 - Can Med Assoc
We read with great interest the CMAJ article by Artenie and colleagues1 showing that the
risk of hepatitis C virus (HCV) infection among people who inject drugs varies con siderably …
risk of hepatitis C virus (HCV) infection among people who inject drugs varies con siderably …
[HTML][HTML] The authors respond to “The 2017 Canadian opioid guideline: already time for an overhaul”
We share their concerns regarding inappropriate opioid tapering. We have highlighted this
concern as it relates to overly aggressive adoption of the US Centers for Disease Control …
concern as it relates to overly aggressive adoption of the US Centers for Disease Control …
Rethinking opioid prescribing to protect patient safety and public health
GC Alexander, SP Kruszewski, DW Webster - Jama, 2012 - jamanetwork.com
PRESCRIPTION DRUGS, INCLUDING AMPHETAMINES, OPI-oids, and benzodiazepines,
provide therapeutic value to millions of Americans. At the same time, there are increasing …
provide therapeutic value to millions of Americans. At the same time, there are increasing …
[PDF][PDF] When will opioid agonist therapy become a normal part of comprehensive health care
P Prathivadi, EA Sturgiss - Med J Aust, 2021 - mja.com.au
Rates of prescribing, morbidity and mortality have dramatically increased since 1990. 1 Fifty-
six percent of unintentional opioid deaths now involve pharmaceutical opioids (as either …
six percent of unintentional opioid deaths now involve pharmaceutical opioids (as either …
Response to “Clarification from the College of Physicians and Surgeons of BC on commentary about limitations of the CDC guideline for prescribing opioids”
The college's fourth standard (https://www. cpsbc. ca/files/pdf/PSG-Safe-Prescribing. pdf),
also a recommendation by the CDC guideline, directs physicians to prescribe opioids at …
also a recommendation by the CDC guideline, directs physicians to prescribe opioids at …
Improving opioid prescribing: the New York City recommendations
ON JANUARY 10, 2013, NEW YORK CITY MAYOR Michael Bloomberg announced new
guide-lines for the prescribing of opioid analgesics to patients being discharged from the …
guide-lines for the prescribing of opioid analgesics to patients being discharged from the …
Opioid prescribing limits for acute pain: potential problems with design and implementation
Recent studies indicate that the amount of opioid medication prescribed for acute pain often
exceeds the amount of opioid actually consumed by patients. 1, 2 Eliminating excessive …
exceeds the amount of opioid actually consumed by patients. 1, 2 Eliminating excessive …
Centers for Disease Control and Prevention Guideline for Prescribing Opioids, 2022—need for integrating dosing benchmarks with shared decision-making
On November 3, 2022, the US Centers for Disease Control and Prevention (CDC) released
a new version1 of its 2016 clinical practice guideline for prescribing opioids. 2 The guideline …
a new version1 of its 2016 clinical practice guideline for prescribing opioids. 2 The guideline …